Literature DB >> 17158875

Direct interactions of Runx2 and canonical Wnt signaling induce FGF18.

Martina I Reinhold1, Michael C Naski.   

Abstract

Canonical Wnt signaling is clearly required for skeletal development and bone formation. However, the targets of Wnt signaling that convert this signal into bone are unclear. Identification of these targets will yield insight into normal bone physiology and suggest new therapeutics for treatment of bone disease. Here we show that an essential regulator of bone development, FGF18, is a direct target of canonical Wnt signaling. A single DNA binding site for the Wnt-dependent transcription factors TCF/Lef accounted for the stimulation of the fgf18 promoter in response to Wnt signaling. Additionally, targeted disruption of betacat blocked fgf18 expression in vivo. Partially overlapping the TCF/Lef binding site is a Runx2 binding site and experiments showed that Runx2 and TCF/Lef work cooperatively to induce fgf18 expression. RNA interference knockdown of Runx2 inhibited and Runx2 forced expression augmented the induction of fgf18 by canonical Wnt signaling. Significantly, Runx2 formed a complex with Lef1 or TCF4 and this complex bound the composite binding site in the fgf18 promoter. These results demonstrate that two transcription pathways that are essential for bone, physically and functionally converge at the fgf18 promoter.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17158875     DOI: 10.1074/jbc.M608995200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

1.  Perichondrial expression of Wdr5 regulates chondrocyte proliferation and differentiation.

Authors:  Francesca Gori; Eric D Zhu; Marie B Demay
Journal:  Dev Biol       Date:  2009-02-13       Impact factor: 3.582

2.  CXXC5 is a negative-feedback regulator of the Wnt/β-catenin pathway involved in osteoblast differentiation.

Authors:  H-Y Kim; J-Y Yoon; J-H Yun; K-W Cho; S-H Lee; Y-M Rhee; H-S Jung; H J Lim; H Lee; J Choi; J-N Heo; W Lee; K T No; D Min; K-Y Choi
Journal:  Cell Death Differ       Date:  2015-01-30       Impact factor: 15.828

Review 3.  Achondroplasia: Development, pathogenesis, and therapy.

Authors:  David M Ornitz; Laurence Legeai-Mallet
Journal:  Dev Dyn       Date:  2017-03-02       Impact factor: 3.780

4.  The RUNX2 cistrome in osteoblasts: characterization, down-regulation following differentiation, and relationship to gene expression.

Authors:  Mark B Meyer; Nancy A Benkusky; J Wesley Pike
Journal:  J Biol Chem       Date:  2014-04-24       Impact factor: 5.157

5.  β-Catenin-dependent FGF signaling sustains cell survival in the anterior embryonic head by countering Smad4.

Authors:  Hunki Paek; Jee-Yeon Hwang; R Suzanne Zukin; Jean M Hébert
Journal:  Dev Cell       Date:  2011-05-17       Impact factor: 12.270

6.  Stage-specific control of connective tissue growth factor (CTGF/CCN2) expression in chondrocytes by Sox9 and beta-catenin.

Authors:  Bau-Lin Huang; Sean M Brugger; Karen M Lyons
Journal:  J Biol Chem       Date:  2010-06-22       Impact factor: 5.157

Review 7.  Mechanisms of synovial joint and articular cartilage development.

Authors:  Ryota Chijimatsu; Taku Saito
Journal:  Cell Mol Life Sci       Date:  2019-06-14       Impact factor: 9.261

Review 8.  Cell cycle and developmental control of hematopoiesis by Runx1.

Authors:  Alan D Friedman
Journal:  J Cell Physiol       Date:  2009-06       Impact factor: 6.384

Review 9.  Disorders of the growth plate.

Authors:  Chanika Phornphutkul; Philip A Gruppuso
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2009-12       Impact factor: 3.243

10.  Transcriptome correlation analysis identifies two unique craniosynostosis subtypes associated with IRS1 activation.

Authors:  B D Stamper; B Mecham; S S Park; H Wilkerson; F M Farin; R P Beyer; T K Bammler; L M Mangravite; M L Cunningham
Journal:  Physiol Genomics       Date:  2012-10-16       Impact factor: 3.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.